Dibutyryl cyclic AMP protects Corynebacterium parvum-treated mice against lipopolysaccharide-induced lethal toxicity

Hidefumi Inoue, Shosuke Takahashi, Kikuo Nomoto, Yasunobu Yoshikai

    Research output: Contribution to journalArticle

    5 Citations (Scopus)

    Abstract

    The effects of dibutyryl cyclic AMP (DBcAMP) on the lethal toxicity of lipopolysaccharide (LPS) were investigated in mice made hypersensitive to LPS by administration with Corynebacterium parvum (C. parvum). The peritoneal macrophages in C. parvum-treated mice released a conspicuous level of TNFα in response to LPS in vitro. These macrophages exhibited much higher susceptibility to LPS-induced cytotoxicity than with resident or peptone-induced macrophages. Pretreatment of the C. parvum-induced macrophages with DBcAM significantly inhibited the TNFα production in response to LPS and decreased the susceptibility to LPS-induced cytotoxicity in vitro. Similar to the findings seen in in vitro experiments, in vivo administration with DBcAMP significantly inhibited the TNFα release in the sera of C. parvum-treated mice after LPS challenge and consequently decreased the susceptibility to LPS-induced shock. These results suggest that raising level of intracellular cAMP protects C. parvum-treated mice from hypersensitivity to lethal toxicity of LPS through downregulating TNFα synthesis.

    Original languageEnglish
    Pages (from-to)1-7
    Number of pages7
    JournalCellular Immunology
    Volume162
    Issue number1
    DOIs
    Publication statusPublished - Apr 1995

    All Science Journal Classification (ASJC) codes

    • Immunology

    Fingerprint Dive into the research topics of 'Dibutyryl cyclic AMP protects Corynebacterium parvum-treated mice against lipopolysaccharide-induced lethal toxicity'. Together they form a unique fingerprint.

  • Cite this